Product
NovoRapid HR011408
Aliases
NovoRapid®；HR011408 injection
1 clinical trial
1 indication
Indication
DiabetesClinical trial
A Single Center, Randomized, Double-Blind, 2-period, 2-sequence Crossover Designed Study to Evaluate the Pharmacokinetics and Pharmacodynamics Between HR011408 and NovoRapid® in Healthy SubjectStatus: Completed, Estimated PCD: 2023-10-26